Interactions of lifetime lead exposure and stress: Behavioral, neurochemical and HPA axis effects

NeuroToxicology

Volumn 32, Issue 1, 2011, Pages 83-99

  Rossi George, A ^a   Virgolini, M B ^a   Weston, D ^b   Thiruchelvam, M ^a   Cory Slechta, D A ^b  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Fixed interval; Frontal cortex; Gender; Lead; Norepinephrine; Postreinforcement pause; Stress

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; CORTICOSTERONE; DOPAMINE; GLUCOCORTICOID RECEPTOR; HOMOVANILLIC ACID; LEAD; NORADRENALIN; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREEDING; CONTROLLED STUDY; CORPUS STRIATUM; ENVIRONMENTAL EXPOSURE; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROGENY; RAT; REINFORCEMENT; STRESS;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; FEMALE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; ORGANOMETALLIC COMPOUNDS; PITUITARY-ADRENAL SYSTEM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS; REINFORCEMENT SCHEDULE;

EID: 78951493323     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2010.09.004     Document Type: Article

References (113)

1. al-Zahrani S.S., al-Ruwaitea A.S., Ho M.Y., Bradshaw C.M., Szabadi E. Destruction of central noradrenergic neurones with DSP4 impairs the acquisition of temporal discrimination but does not affect memory for duration in a delayed conditional discrimination task. Psychopharmacology (Berlin) 1997, 130:166-173.
2. Anderson N.B., Armstead C.A. Toward understanding the asociation of socioeconomic status and health: A new challenge for the biopsychosocial approach. Psychosom Med 1995, 57:213-225.
3. Arnsten A.F. Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms. Prog Brain Res 2000, 126:183-192.
4. Barrot M., Marinelli M., Abrous D.N., Rouge-Pont F., Le Moal M., Piazza P.V. The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci 2000, 12:973-979.
5. Bellinger D.C., Hu H., Titlebaum L., Needleman H.L. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health 1994, 49:98-105.
6. Beydoun H., Saftlas A.F. Physical and mental health outcomes of prenatal maternal stress in human and animal studies: a review of recent evidence. Paediatr Perinat Epidemiol 2008, 22:438-466.
7. Bradley R.H., Corwyn R.F. Socioeconomic status and child development. Annu Rev Psychol 2002, 53:371-399.
8. Bruce M.A., Beech B.M., Sims M., Brown T.N., Wyatt S.B., Taylor H.A., et al. Social environmental stressors, psychological factors, and kidney disease, J. Investig Med 2009, 57:583-589.
9. Canfield R.L., Henderson C.R., Cory-Slechta D.A., Cox C., Jusko T.A., Lanphear B.P. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 2003, 348:1517-1526.
10. Canfield R.L., Gendle M.H., Cory-Slechta D.A. Impaired neuropsychological functioning in lead-exposed children. Dev Neuropsychol 2004, 26:513-540.
11. Cheng Y., Schwartz J., Sparrow D., Aro A., Weiss S.T., Hu H. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. Am J Epidemiol 2001, 153:164-171.
12. Cohen S., Doyle W.J., Baum A. Socioeconomic status is associated with stress hormones. Psychosom Med 2006, 68:414-420.
13. Cory-Slechta D.A. Alterations in tissue Pb distribution and hematopoietic indices during advanced age. Arch Toxicol 1990, 64:31-37.
14. Cory-Slechta D.A. Lead exposure during advanced age: alterations in kinetics and biochemical effects. Toxicol Appl Pharmacol 1990, 104:67-78.
15. Cory-Slechta D.A. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic and glutamatergic neurotransmitter system functions. Annu Rev Pharmacol Toxicol 1995, 35:391-415.
16. Cory-Slechta D.A. Comparative neurobehavioral toxicology of heavy metals. Toxicology of metals 1996, 537-560. CRC Press, New York. T. Suzuki (Ed.).
17. Cory-Slechta DA. Studying toxicants as single chemicals: does this strategy adequately identify neurotoxic risk? Neurotoxicology (2005).
18. Cory-Slechta D.A., Pokora M.J. Behavioral manifestations of prolonged lead exposure initiated at different stages of the life cycle: I. Schedule-controlled responding. Neurotoxicology 1991, 12:745-760.
19. Cory-Slechta D.A., Thompson T. Behavioral toxicity of chronic postweaning lead exposure in the rat. Toxicol Appl Pharmacol 1979, 47:151-159.
20. Cory-Slechta D.A., Weiss B. Alterations in schedule-controlled behavior of rodents correlated with prolonged lead exposure. Behavioral pharmacology: the current status 1985, 487-501. Alan R. Liss, New York. R.L. Balster (Ed.).
21. Cory-Slechta D.A., Weiss B., Cox C. Delayed behavioral toxicity of lead with increasing exposure concentration. Toxicol Appl Pharmacol 1983, 71:342-352.
22. Cory-Slechta D.A., Weiss B., Cox C. Performance and exposure indices of rats exposed to low concentrations of lead. Toxicol Appl Pharmacol 1985, 78:291-299.
23. Cory-Slechta D.A., Weiss B., Cox C. Tissue distribution of Pb in adult vs. old rats: a pilot study. Toxicology 1989, 59:139-150.
24. Cory-Slechta D.A., Pokora M.J., Widzowski D.V. Behavioral manifestations of prolonged lead exposure initiated at different stages of the life cycle: II. Delayed spatial alternation. Neurotoxicology 1991, 12:761-776.
25. Cory-Slechta D.A., Pazmino R., Bare C. The critical role of the nucleus accumbens dopamine systems in the mediation of fixed interval schedule-controlled operant behavior. Brain Res 1997, 764:253-256.
26. Cory-Slechta D.A., O'Mara D.J., Brockel B.J. Nucleus accumbens dopaminergic mediation of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure. J Pharmacol Exp Ther 1998, 286:794-805.
27. Cory-Slechta D.A., O'Mara D.J., Brockel B.J. Learning versus performance impairments following regional administration of MK-801 into nucleus accumbens and dorsomedial striatum. Behav Brain Res 1999, 102:181-194.
28. Cory-Slechta D.A., Brockel B.J., O'Mara D.J. Lead exposure and dorsomedial striatum mediation of fixed interval schedule-controlled behavior. Neurotoxicology 2002, 23:313-327.
29. Cory-Slechta D.A., Virgolini M.B., Thiruchelvam M., Weston D.D., Bauter M.R. Maternal stress modulates the effects of developmental lead exposure. Environ Health Perspect 2004, 112:717-730.
30. Cory-Slechta D.A., Virgolini M.B., Rossi-George A., Thiruchelvam M., Lisek R., Weston D. Lifetime consequences of combined maternal lead and stress. Basic Clin Pharmacol Toxicol 2008, 102:218-227.
31. Cory-Slechta D.A., Virgolini M.B., Rossi-George A., Weston D., Thiruchelvam M. Experimental manipulations blunt time-induced changes in brain monoamine levels and completely reverse stress, but not Pb±stress-related modifications to these trajectories. Behav Brain Res 2009, 205:76-87.
32. Darcheville J.C., Riviere V., Wearden J.H. Fixed-interval performance and self-control in children. J Exp Anal Behav 1992, 57:187-199.
33. Darcheville J.C., Riviere V., Wearden J.H. Fixed-interval performance and self-control in infants. J Exp Anal Behav 1993, 60:239-254.
34. Davis J.M., Svendsgaard D.J. U-shaped dose-response curve-shaped dose-response curves: their occurrence and implications for risk assessment. J Toxicol Environ Health 1990, 30:71-83.
35. de Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998, 19:269-301.
36. De Vriendt T., Moreno L.A., De Henauw S. Chronic stress and obesity in adolescents: scientific evidence and methodological issues for epidemiological research. Nutr Metab Cardiovasc Dis 2009, 19:511-519.
37. Diaz R, Sokoloff P., Fuxe K. Codistribution of the dopamine D3 receptor and glucocorticoid receptor mRNAs during striatal prenatal development in the rat. Neurosci Lett 1997, 227:119-122.
38. Dietrich K.N., Ris M.D., Succop P.A., Berger O.G., Bornschein R. Early exposure to lead and juvenile delinquency. Neurotoxicol Teratol 2001, 23:511-518.
39. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 1993, 13:3839-3847.
40. Dohrenwend B.P. Social status and stressful life events. J Pers Soc Psychol 1973, 28:225-235.
41. Drasch G.A., Bohm J., Baur C. Lead in human bones. Investigations of an occupationally non-exposed population in southern Bavaria (FRG). I: Adults. Sci Total Environ 1987, 64:303-315.
42. Du J., Wang Y., Hunter R., Wei Y., Blumenthal R., Falke C., et al. Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci USA 2009, 106:3543-3548.
43. Evans S.B., Cory-Slechta D.A. Prefrontal cortical manipulations alter the effects of intra-ventral striatal dopamine antagonists on fixed-interval performance in the rat. Behav Brain Res 2000, 17:45-58.
44. Evans G.W., Schamberg M.A. Childhood poverty, chronic stress, and adult working memory. Proc Natl Acad Sci USA 2009, 106:6545-6549.
45. Figueredo V.M. The time has come for physicians to take notice: the impact of psychosocial stressors on the heart. Am J Med 2009, 122:704-712.
46. Flaherty E.G., Thompson R., Litrownik A.J., Zolotor A.J., Dubowitz H., Runyan D.K., et al. Adverse childhood exposures and reported child health at age 12. Acad Pediatr 2009, 9:150-156.
47. Flora G.J.S., Seth P.K., Flora S.J.S. Recoveries in lead induced alterations in rat brain biogenic amine levels following combined chelation therapy with meso 2,3-dimercaptosuccinic acid and calcium disodium versenate. Biogenic Amines 1997, 13:79-90.
48. Gaitens J.M., Dixon S.L., Jacobs D.E., Nagaraja J., Strauss W., Wilson J.W., et al. Exposure of U.S. children to residential dust lead 1999-2004: I. Housing and demographic factors. Environ Health Perspect 2009, 117:461-467.
49. Gerr F., Letz R., Stokes L., Chettle D., McNeill F., Kaye W. Association between bone lead concentration and blood pressure among young adults. Am J Ind Med 2002, 42:98-106.
50. Grizenko N., Shayan Y.R., Polotskaia A., Ter-Stepanian M., Joober R. Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci 2008, 33:10-16.
51. Haley V.B., Talbot T.O. Geographic analysis of blood lead levels in New York State children born 1994-1997. Environ Health Perspect 2004, 112:1577-1582.
52. Hashmi N.S., Kachru D.N., Khandelwal S., Tandon S.K. Interrelationship between iron deficiency and lead intoxication (Part 2). Biol Trace Elem Res 1989, 22:299-307.
53. Hashmi N.S., Kachru D.N., Tandon S.K. Interrelationship between iron deficiency and lead intoxication (Part 1). Biol Trace Elem Res 1989, 22:287-297.
54. He K., Wang S., Zhang J. Blood lead levels of children and its trend in China. Sci Total Environ 2009, 407:3986-3993.
55. Hrdina P.D., Hanin I., Dubas T.C. Neurochemical correlates of lead toxicity. Lead toxicity 1980, 273-300. Urban & Schwarzenberg, Baltimore. J.A. Thomas (Ed.).
56. Joels M. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol Sci 2006, 27:244-250.
57. Jones R.L., Homa D.M., Meyer P.A., Brody D.J., Caldwell K.L., Pirkle J.L., et al. Trends in blood lead levels and blood lead testing among US children aged 1 to 5 years, 1988-2004. Pediatrics 2009, 123:e376-e385.
58. Kelleher R.T., Morse W.H. Determinants of the behavioral effects of drugs. Importance of fundamental principles in drug evaluation 1969, 383-405. Raven Press, New York. R. Tedeschi (Ed.).
59. Kemp F.W., Neti P.V., Howell R.W., Wenger P., Louria D.B., Bogden J.D. Elevated blood lead concentrations and vitamin D deficiency in winter and summer in young urban children. Environ Health Perspect 2007, 115:630-635.
60. Kemper A.R., Cohn L.M., Fant K.E., Dombkowski K.J., Hudson S.R. Follow-up testing among children with elevated screening blood lead levels. JAMA 2005, 293:2232-2237.
61. Kern M., Audesirk G. Stimulatory and inhibitory effects of inorganic lead on calcineurin. Toxicology 2000, 150:171-178.
62. Kim R., Hu H., Rotnitzky A., Bellinger D., Needleman H. A longitudinal study of chronic lead exposure and physical growth in Boston children. Environ Health Perspect 1995, 103:952-957.
63. Kitaoka-Higashiguchi K., Morikawa Y., Miura K., Sakurai M., Ishizaki M., Kido T., et al. Burnout and risk factors for arteriosclerotic disease: follow-up study. J Occup Health 2009, 51:123-131.
64. Koolhaas J.M., Meerlo P., De Boer S.F., Strubbe J.H., Bohus B. The temporal dynamics of the stress response. Neurosci Biobehav Rev 1997, 21:775-782.
65. Lanphear B.P., Hornung R., Khoury J., Yolton K., Baghurst P., Bellinger D.C., et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 2005, 113:894-899.
66. Leasure J.L., Giddabasappa A., Chaney S., Johnson J.E., Pothakos K., Lau Y.S., et al. Low-level human equivalent gestational lead exposure produces sex-specific motor and coordination abnormalities and late-onset obesity in year-old mice. Environ Health Perspect 2008, 116:355-361.
67. Little H.J., Croft A.P., O'Callaghan M.J., Brooks S.P., Wang G., Shaw S.G. Selective increases in regional brain glucocorticoid: a novel effect of chronic alcohol. Neuroscience 2008, 156:1017-1027.
68. Lowy M., Gault L., Yammamato B. Adrenalectomy attenuates stress induced elevation in extracellular glutamate concentration in hippocampus. J Neurosci 1993, 61:1957-1960.
69. Lupien S.J., King S., Meaney M.J., McEwen B.S. Child's stress hormone levels correlate with mother's socioeconomic status and depressive state. Biol Psychiatry 2000, 48:976-980.
70. Lupien S.J., King S., Meaney M.J., McEwen B.S. Can poverty get under your skin? Basal cortisol levels and cognitive function in children from low and high socioeconomic status. Dev Psychopathol 2001, 13:653-676.
71. Mahaffey K.R. Nutritional factors and susceptibility to lead toxicity. Environ Health Perspect 1974, 7:107-112.
72. Mahaffey K.R., Goyer R., Haseman J.K. Dose-response to lead ingestion in rats fed low dietary calcium. J Lab Clin Med 1973, 82:92-100.
73. Manea-Krichten M., Patterson C., Miller G., Settle D., Erel Y. Comparative increases of lead and barium with age in human tooth enamel, rib and ulna. Sci Total Environ 1991, 107:179-203.
74. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007, 87:873-904.
75. McEwen B.S. Understanding the potency of stressful early life experiences on brain and body function. Metabolism 2008, 2(57 Suppl.):S11-S15.
76. McEwen B.S., Seeman T. Protective and damaging effects of mediators of stress Elaborating and testing the concepts of allostasis and allostatic load. Ann NY Acad Sci 1999, 896:30-47.
77. Meck W.H., Penney T.B., Pouthas V. Cortico-striatal representation of time in animals and humans. Curr Opin Neurobiol 2008, 18:145-152.
78. Menke A., Muntner P., Batuman V., Silbergeld E.K., Guallar E. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation 2006, 114:1388-1394.
79. Miller G.E., Chen E., Fok A.K., Walker H., Lim A., Nicholls E.F., et al. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc Natl Acad Sci USA 2009, 106:14716-14721.
80. Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry 2002, 51:775-787.
81. Morgane P.J., Galler J.R., Mokler D.J. A review of systems and networks of the limbic forebrain/limbic midbrain. Prog Neurobiol 2005, 75:143-160.
82. Morilak D.A., Barrera G., Echevarria D.J., Garcia A.S., Hernandez A., Ma S., et al. Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1214-1224.
83. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984, 5:25-44.
84. Needleman H.L., Riess J.A., Tobin M.J., Biesecker G.E., Greenhouse J.B. Bone lead levels and delinquent behavior. J Am Med Assoc 1996, 275:363-369.
85. Opler M.G., Brown A.S., Graziano J.H., Desai M., Zheng W., Schaefer C., et al. Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia, Environ. Health Perspect 2004, 112:548-552.
86. Pallares M.E., Scacchi Bernasconi P.A., Feleder C., Cutrera R.A. Effects of prenatal stress on motor performance and anxiety behavior in Swiss mice. Physiol Behav 2007, 92:951-956.
87. Park C.R., Campbell A.M., Woodson J.C., Smith T.P., Fleshner M., Diamond D.M. Permissive influence of stress in the expression of a u-shaped relationship between serum corticosterone levels and spatial memory errors in rats. Dose Response 2006, 4:55-74.
88. Piazza P.V., Rouge-Pont F., Deroche V., Maccari S., Simon H., Le Moal M. glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci USA 1996, 93:8716-8720.
89. Pokora M.J., Richfield E.K., Cory-Slechta D.A. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments. J Neurochem 1996, 67:1540-1550.
90. Pounds J.G. Effect of lead intoxication on calcium homeostasis and calcium-mediated cell function: a review. Neurotoxicology 1984, 5:295-331.
91. Rajan P., Kelsey K.T., Schwartz J.D., Bellinger D.C., Weuve J., Sparrow D., et al. Lead burden and psychiatric symptoms and the modifying influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism: the VA Normative Aging Study. Am J Epidemiol 2007, 166:1400-1408.
92. Rammsayer T.H., Hennig J., Haag A., Lange N. Effects of noradrenergic activity on temporal information processing in humans. Q J Exp Psychol B 2001, 54:247-258.
93. Rhodes D., Spiro A., Aro H., Hu Relationship of bone and blood lead levels to psychiatric symptoms: the normative aging study. J Occup Environ Med 2003, 45:1144-1151.
94. Rinaudo P.F., Lamb J. Fetal origins of perinatal morbidity and/or adult disease. Semin Reprod Med 2008, 26:436-445.
95. Rossi-George A., Virgolini M.B., Weston D., Cory-Slechta D.A. Alterations in glucocorticoid negative feedback following maternal Pb, prenatal stress and the combination: a potential biological unifying mechanism for their corresponding disease profiles. Toxicol Appl Pharmacol 2009, 234:117-127.
96. Rouge-Pont F., Deroche V., Le Moal M., Piazza P.V. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur J Neurosci 1998, 10:3903-3907.
97. Rubia K., Halari R., Christakou A., Taylor E. Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate. Philos Trans R Soc Lond B Biol Sci 2009, 364:1919-1931.
98. Schneider M.L., Clarke S.A., Kraemer G.W., Roughton E.C., Lubach G.R., Rimm-Kaufman S., et al. Prenatal stress alters brain biogenic amine levels in primates. Dev Psychopathol 1998, 10:427-440.
99. Schwartz J. Low-level lead exposure and children's IQ: a meta-analysis and search for a threshold. Environ Res 1994, 65:42-55.
100. Sonuga-Barke E.J.S, Taylor E., Sembi S., Smith J. Hyperactivity and delay aversion-I. The effect of delay on choice. J Child Psychol Psychiatry 1992, 33:387-398.
101. Stephens D.W., Krebs J.R. Foraging theory 1986, Princeton University Press, Princeton, NJ.
102. Takahashi L.K., Turner J.G., Kalin N.H. Prenatal stress alters brain catecholaminergic activity and potentiates stress-induced behavior in adult rats. Brain Res 1992, 574:131-137.
103. van Wijngaarden E., Campbell J.R., Cory-Slechta D.A. Bone lead levels are associated with measures of memory impairment in older adults. Neurotoxicology 2009, 30:572-580.
104. Vere C.C., Streba C.T., Streba L.M., Ionescu A.G., Sima F. Psychosocial stress and liver disease status. World J Gastroenterol 2009, 15:2980-2986.
105. Virgolini M.B., Chen K., Weston D.D., Bauter M.R., Cory-Slechta D.A. Interactions of chronic lead exposure and intermittent stress: consequences for brain catecholamine systems and associated behaviors and HPA axis function. Toxicol Sci 2005, 87:469-482.
106. Virgolini M.B., Bauter M.R., Weston D.D., Cory-Slechta D.A. Permanent alterations in stress responsivity in female offspring subjected to combined maternal lead exposure and/or stress. Neurotoxicology 2006, 27:11-21.
107. Virgolini M.B., Rossi-George A., Lisek R., Weston D.D., Thiruchelvam M., Cory-Slechta D.A. CNS effects of developmental Pb exposure are enhanced by combined maternal and offspring stress. Neurotoxicology 2008, 29:812-827.
108. Virgolini M.B., Rossi-George A., Weston D., Cory-Slechta D.A. Influence of low level maternal Pb exposure and prenatal stress on offspring stress challenge responsivity. Neurotoxicology 2008, 29:928-939.
109. Von Korff M., Alonso J., Ormel J., Angermeyer M., Bruffaerts R., Fleiz C., et al. Childhood psychosocial stressors and adult onset arthritis: broad spectrum risk factors and allostatic load. Pain 2009, 143:76-83.
110. Vyskocil A, Smejkalova J, Lacinova V. Dose-related stress reaction in male rats chronically exposed to lead acetate, Sb. Ved. Pr. Lek. Fak. Karlovy Univerzity Hradci Kralove 34 (1991) 393-401.
111. Ward I.L., Weisz J. Differential effects of maternal stress on circulating levels of corticosterone, progesterone and testosterone in male and female rat fetuses and their mothers. Endocrinology 1984, 114:1635-1644.
112. Wittmann M., Paulus M.P. Decision making, impulsivity and time perception. Trends Cogn Sci 2008, 12:7-12.
113. Yi S.J., Masters J.N., Baram T.Z. Glucocorticoid receptor mRNA ontogeny in the fetal and postnatal rat forebrain. Mol Cell Neurosci 1994, 5:385-393.